iShares Neuroscience and Healthcare ETF Rating $30.01 -0.29 (-0.97%) As of 02:54 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatings iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy 2.70Holdings in IBRN have an aggregate rating of Moderate Buy based on 327 analyst ratings issued in the past year covering 19 companies (63.6% of the portfolio).IBRN Aggregate Price Target$30.190.44% UpsideHigh Prediction$30.19Average Prediction$30.19Low Prediction$30.19Holdings in IBRN have an aggregate price target of $30.19 and a range of $30.19 to $30.19 covering 19 companies (63.6% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy1 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce2 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 19 IBRN Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings4.86%BIIBBiogen$231.73+1.2%Moderate Buy$236.04 1.9%322.6114 of 5 starsAnalyst Upgrade4.47%EWTXEdgewise Therapeutics$37.44+3.2%Moderate Buy$51.33 37.1%112.7215 of 5 starsAnalyst Forecast4.46%NBIXNeurocrine Biosciences$135.55+0.3%Moderate Buy$201.14 48.4%244.8202 of 5 starsNews CoverageAnalyst Forecast4.43%PTCTPTC Therapeutics$59.56-0.6%Moderate Buy$98.25 65.0%154.0386 of 5 stars4.27%ALKSAlkermes$39.24-1.2%Moderate Buy$54.47 38.8%193.1987 of 5 stars3.90%ARGXargenex$824.88+2.8%Moderate Buy$1,151.95 39.7%304.7092 of 5 starsAnalyst Forecast3.74%DNTHDianthus Therapeutics$75.08-3.2%Moderate Buy$129.83 72.9%152.4678 of 5 starsNews Coverage3.74%SRRKScholar Rock$39.62-2.2%Moderate Buy$67.67 70.8%173.0865 of 5 stars3.67%PRAXPraxis Precision Medicines$239.29-1.7%Moderate Buy$613.26 156.3%202.6439 of 5 starsNews Coverage3.56%SUPNSupernus Pharmaceuticals$41.07-2.2%Hold$62.40 51.9%63.4129 of 5 starsNews Coverage3.43%ACADACADIA Pharmaceuticals$19.05+2.3%Moderate Buy$31.34 64.6%184.718 of 5 starsTrending NewsAnalyst Upgrade3.31%DYNDyne Therapeutics$14.88-2.7%Moderate Buy$33.07 122.3%163.3712 of 5 stars2.97%XENEXenon Pharmaceuticals$33.71-2.1%Moderate Buy$70.14 108.1%154.4065 of 5 starsAnalyst Downgrade2.94%AXGNAxoGen$35.46-2.0%Moderate Buy$51.73 45.9%153.2216 of 5 starsAnalyst Forecast2.85%SRPTSarepta Therapeutics$16.69+1.1%Reduce$22.59 35.4%213.3657 of 5 starsAnalyst Upgrade2.38%BHVNBiohaven$10.88-4.7%Moderate Buy$18.69 71.8%173.3977 of 5 stars1.81%TSHATaysha Gene Therapies$3.53-1.5%Buy$12.77 262.2%152.376 of 5 stars1.42%LBRXLB Pharmaceuticals$34.25-1.5%Moderate Buy$57.40 67.6%132.4179 of 5 starsAnalyst Downgrade1.38%IARTIntegra LifeSciences$13.08-5.6%Reduce$16.71 27.8%83.548 of 5 starsUpcoming EarningsAnalyst ForecastGap Down This page (NYSEARCA:IBRN) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredWhy Some AI Stocks Already Surged Over 300 PercentJason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run...Brownstone Research | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredElon pays this company. Every time.Every Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Star...Behind the Markets | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBRN Stock Alerts